Print this page

Transcranial Magnetic Stimulation: A New Treatment Option for Depression

Linda Carpenter, M.D. and Stephan Taylor, M.D.

Dr. Stephan Taylor and Dr. Linda Carpenter discuss a new treatment option for depression, Transcranial Magnetic Stimulation (TMS). Dr. Taylor discusses the importance of neuromodulation and the targets for neuromodulation, while Dr. Carpenter looks into the future, and addresses where TMS is heading. Dr. Taylor discusses that the bases behind a neuromodulation technique is to have a therapeutic intervention that interacts with the brain and then changes it. The effects of this treatment are complex and depend upon a variety of variables. Dr. Taylor then discusses the many varieties of repetitive TMS (rTMS). To target neuromodulation, one has to look at the emotional regions of the brain. With TMS, the areas of the brain that need to be targeted are the areas involved in cognitive control, executive functioning, and the areas that allow one to carry out tasks without the interference of emotion. TMS is used in the dorsal and prefrontal cortex of the brain, but it affects each individual differently. Dr. Taylor concludes that TMS is a powerful tool to modulate brain function, with a few disadvantages and many advantages. Dr. Carpenter continues with the future of TMS and shows a video where someone is using the Neurostar TMS system. She discusses the small side effects related to TMS and the relevance for clinical TMS practice. Dr. Carpenter discusses different studies to further explain the relevance for clinical TMS practice. She continues with the fact that TMS is original because it has built a mechanism for keeping data, which is helpful for patients, for the future to see what works, and to see what symptoms are responding to the treatment. She ends with the evolving standard of TMS care.


Click here to view the archived webcast - log in required